Notice of Intent to Sole Source services to maintain regular access to Advanced Photon Source (APS) - SER-CAT beam lines
Inactive on SAM.gov — responses were due 5 Jul 2026 · No Set aside used · Centers for Disease Control and Prevention (CDC), HHS · Athens, GA · NAICS 541380 · Solicitation 75D30126Q79042
Following NAICS 541380? Get new solicitations in it by email as they post — no account needed.
SAM.gov marked this notice inactive — responses were due 05 July 2026.
No award notice on SAM.gov yet. Not every award is posted there, so this does not mean it went unawarded.
Email me when the award is announced. One email, when SAM.gov posts the award notice. Not every award is posted there; if none appears within six months we'll tell you and stop. No account needed.
Likely sole source (FedSift estimate from the notice text) — confirm on SAM.gov before investing in a bid
Get new NAICS 541380 solicitations by email
This one has closed. We'll email you when new NAICS 541380 (Testing Laboratories and Services) solicitations post — the first email lists what is open right now, then at most once a week, only when something new posts. No account needed; unsubscribe in a click.
Description
The Centers for Disease Control and Prevention Nation Center for Immunization and Respiratory Diseases (NCIRD), Influenza Division (ID) intends to award a sole source Firm-fixed-price purchase order to The University of Georgia Research Foundation, Inc. (UGARF) to maintain regular access to their Advanced Photon Source (APS) - SER-CAT beam lines for sample processing and data collection using their highly specialized equipment and support from their onsite qualified laboratory personnel to collect, analyze, interpret, and evaluate structural data from viral proteins from pandemic or seasonal influenza viruses. This contract action is for commercial services for which the Government intends to solicit and negotiate with only one source under the authority of FAR 12.102(a). NAICS 541380 - Testing Laboratories and Services. UGARF is the only source providing the most advanced macromolecular crystallography capabilities currently available in the United States. Use of lower-intensity beamlines available through other facilities would result in reduced data quality and diminished analytical capability. In addition, UGARF, through the use of their APS - SER-CAT beam lines, provides CDC guaranteed beam access during public health emergencies, which is critical to supporting urgent influenza response and preparedness activities. Use of an alternative facility is not feasible due to significant compatibility and transition limitations currently in place. This notice of intent is not a request for competitive quotations; however, all Quotations/ responses received within 15 days of the issuance of this notice shall be considered by the government. A determination by the government not to complete this proposed contract based upon responses to this notice is solely within the discretion of the government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement. Any quotation/response should be emailed to the contract specialist at email zvm0@cdc.gov by 07/05/2026.
Go deeper on this solicitation
FedSift reads the full solicitation package — every attachment — and pre-extracts the compliance matrix, evaluation factors, key risks, win themes and deal-breakers, each with a verbatim quote and the exact PDF page it came from. It scores the opportunity against your company profile, tells you whether to bid as prime or sub, and ranks teaming partners who could close your gaps.
Source: this notice on SAM.gov. FedSift republishes public federal procurement data and is not affiliated with the U.S. Government. Always confirm dates and requirements against SAM.gov before responding.
